$22.50
0.894.14%
À la clôture: Nov 13, 4:00 PM EST
$22.06
0.462.13%
Pré-ouverture: 7:00 AM EST

The average analyst price target for Damora Therapeutics is $48.57, 120.2% above the current price. Of 6 analysts, 6 rate it Buy. Targets range from $40 to $60. The latest change came on Nov 6, 2026, when Guggenheim lowered its price target on Damora Therapeutics from $60 to $59 and kept a Buy rating.
Price Target Range — 4 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months